Success Metrics

Clinical Success Rate
83.3%

Based on 15 completed trials

Completion Rate
83%(15/18)
Active Trials
15(25%)
Results Posted
13%(2 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_4
2
3%
Ph phase_3
1
2%
Ph not_applicable
44
73%
Ph phase_2
4
7%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution51 total trials
Phase 2Efficacy & side effects
4(7.8%)
Phase 3Large-scale testing
1(2.0%)
Phase 4Post-market surveillance
2(3.9%)
N/ANon-phased studies
44(86.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

15 of 20 finished

Non-Completion Rate

25.0%

5 ended early

Currently Active

15

trials recruiting

Total Trials

60

all time

Status Distribution
Active(23)
Completed(15)
Terminated(5)
Other(17)

Detailed Status

unknown17
Completed15
Recruiting9
Not yet recruiting8
Active, not recruiting6
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
60
Active
15
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (7.8%)
Phase 31 (2.0%)
Phase 42 (3.9%)
N/A44 (86.3%)

Trials by Status

completed1525%
terminated35%
not_yet_recruiting813%
active_not_recruiting610%
recruiting915%
unknown1728%
withdrawn23%

Recent Activity

Clinical Trials (60)

Showing 20 of 60 trialsScroll for more
NCT04282850Not Applicable

Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

Terminated
NCT06861673

COCONUT Study Concomitant PVI and LAAC

Recruiting
NCT06935591Not Applicable

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Recruiting
NCT07450755Not Applicable

Concomitant PFA Bsaed PVI Plus LAAC

Not Yet Recruiting
NCT07380932Not Applicable

Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair

Not Yet Recruiting
NCT04503122

Baroreflex Sensitivity in Patients Undergoing Ablation of Atrial Fibrillation

Completed
NCT07238452Phase 4

Optimising Pacing Therapy, Integrated Medical Therapy, and Catheter AbLation for Atrial Fibrillation in Heart Failure Trial

Not Yet Recruiting
NCT05119231Not Applicable

Pulmonary Vein Isolation vs SHAM-pulmonary Vein Isolation for Symptomatic Relief in Patients With AF

Active Not Recruiting
NCT07175727Not Applicable

TWOSOME Trial: Single-Shot Versus Single-Tip Pulsed Field Ablation for Pulmonary Vein Isolation

Completed
NCT07118046Not Applicable

Comparison of Fluoroscopy-only vs. Electroanatomic Mapping Strategies for Pulmonary Vein Isolation With Balloon-based Pulsed-field Ablation

Recruiting
NCT06096246Not Applicable

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

Recruiting
NCT05251545Not Applicable

Randomized Trial: High Power Short Duration Versus Ablation Index

Completed
NCT07059208Not Applicable

Atrioventricular Nodal Ablation Versus Pulmonary Vein Isolation - Patient Centred Decisions

Not Yet Recruiting
NCT03907982Not Applicable

Investigation of Therapeutic Ablation Versus Cardioversion for AF

Completed
NCT05870306Not Applicable

Triple Atria Extrastimuli vs Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation

Active Not Recruiting
NCT06929897Not Applicable

PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF

Not Yet Recruiting
NCT06220006Not Applicable

Lesion Formation With Pulsed Field Versus Cryobaloon Ablation as Assessed by Cardiac Magnetic Resoncance

Recruiting
NCT06671197

Study on the Ablation of Persistent Atrial Fibrillation Using Pulsed Electric Fields Under Different Surgical Procedures

Not Yet Recruiting
NCT06846502Not Applicable

High Power Short Duration Radiofrequency Ablation of Atrial Fibrillation Using the QDOT MICRO™ Catheter

Active Not Recruiting
NCT06183619

Superior Vena Cava Isolation Plus Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

Active Not Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
60